Global Biopharmaceuticals Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 28-Jun-2021
No. of pages: 109
Inquire Before Buying

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

It is costly to discover and develop new drugs/medicines due to expensive research processes, Costs associated with clinical trials, resource-intensive approval procedures and costs associated

With manufacturing (if the trials are successful).

Market Analysis and Insights: Global Biopharmaceuticals Market

The global Biopharmaceuticals market size is projected to reach US$ 113300 million by 2027, from US$ 82330 million in 2020, at a CAGR of 4.7% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceuticals market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceuticals market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceuticals market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceuticals market.

Global Biopharmaceuticals Scope and Market Size

Biopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Monoclonal Antibodies

- Interferon

- Colony-Stimulating Factor

- Erythropoietin

- Insulin

- Vaccines

- Growth Hormones

- Others

Segment by Application

- Tumor

- Diabetes

- Cardiovascular

- Hemophilia

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Roche

- Amgen

- AbbVie

- Sanofi-Aventis

- Johnson & Johnson

- Pfizer

- Novo Nordisk

- Eli Lilly

- Novartis

- Merck

Global Biopharmaceuticals Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceuticals Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Colony-Stimulating Factor
1.2.5 Erythropoietin
1.2.6 Insulin
1.2.7 Vaccines
1.2.8 Growth Hormones
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biopharmaceuticals Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceuticals Market Perspective (2016-2027)
2.2 Biopharmaceuticals Growth Trends by Regions
2.2.1 Biopharmaceuticals Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biopharmaceuticals Historic Market Share by Regions (2016-2021)
2.2.3 Biopharmaceuticals Forecasted Market Size by Regions (2022-2027)
2.3 Biopharmaceuticals Industry Dynamic
2.3.1 Biopharmaceuticals Market Trends
2.3.2 Biopharmaceuticals Market Drivers
2.3.3 Biopharmaceuticals Market Challenges
2.3.4 Biopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceuticals Players by Revenue
3.1.1 Global Top Biopharmaceuticals Players by Revenue (2016-2021)
3.1.2 Global Biopharmaceuticals Revenue Market Share by Players (2016-2021)
3.2 Global Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceuticals Revenue
3.4 Global Biopharmaceuticals Market Concentration Ratio
3.4.1 Global Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceuticals Revenue in 2020
3.5 Biopharmaceuticals Key Players Head office and Area Served
3.6 Key Players Biopharmaceuticals Product Solution and Service
3.7 Date of Enter into Biopharmaceuticals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceuticals Breakdown Data by Type
4.1 Global Biopharmaceuticals Historic Market Size by Type (2016-2021)
4.2 Global Biopharmaceuticals Forecasted Market Size by Type (2022-2027)
5 Biopharmaceuticals Breakdown Data by Application
5.1 Global Biopharmaceuticals Historic Market Size by Application (2016-2021)
5.2 Global Biopharmaceuticals Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biopharmaceuticals Market Size (2016-2027)
6.2 North America Biopharmaceuticals Market Size by Type
6.2.1 North America Biopharmaceuticals Market Size by Type (2016-2021)
6.2.2 North America Biopharmaceuticals Market Size by Type (2022-2027)
6.2.3 North America Biopharmaceuticals Market Size by Type (2016-2027)
6.3 North America Biopharmaceuticals Market Size by Application
6.3.1 North America Biopharmaceuticals Market Size by Application (2016-2021)
6.3.2 North America Biopharmaceuticals Market Size by Application (2022-2027)
6.3.3 North America Biopharmaceuticals Market Size by Application (2016-2027)
6.4 North America Biopharmaceuticals Market Size by Country
6.4.1 North America Biopharmaceuticals Market Size by Country (2016-2021)
6.4.2 North America Biopharmaceuticals Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biopharmaceuticals Market Size (2016-2027)
7.2 Europe Biopharmaceuticals Market Size by Type
7.2.1 Europe Biopharmaceuticals Market Size by Type (2016-2021)
7.2.2 Europe Biopharmaceuticals Market Size by Type (2022-2027)
7.2.3 Europe Biopharmaceuticals Market Size by Type (2016-2027)
7.3 Europe Biopharmaceuticals Market Size by Application
7.3.1 Europe Biopharmaceuticals Market Size by Application (2016-2021)
7.3.2 Europe Biopharmaceuticals Market Size by Application (2022-2027)
7.3.3 Europe Biopharmaceuticals Market Size by Application (2016-2027)
7.4 Europe Biopharmaceuticals Market Size by Country
7.4.1 Europe Biopharmaceuticals Market Size by Country (2016-2021)
7.4.2 Europe Biopharmaceuticals Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceuticals Market Size (2016-2027)
8.2 Asia-Pacific Biopharmaceuticals Market Size by Type
8.2.1 Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biopharmaceuticals Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2027)
8.3 Asia-Pacific Biopharmaceuticals Market Size by Application
8.3.1 Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biopharmaceuticals Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2027)
8.4 Asia-Pacific Biopharmaceuticals Market Size by Region
8.4.1 Asia-Pacific Biopharmaceuticals Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biopharmaceuticals Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biopharmaceuticals Market Size (2016-2027)
9.2 Latin America Biopharmaceuticals Market Size by Type
9.2.1 Latin America Biopharmaceuticals Market Size by Type (2016-2021)
9.2.2 Latin America Biopharmaceuticals Market Size by Type (2022-2027)
9.2.3 Latin America Biopharmaceuticals Market Size by Type (2016-2027)
9.3 Latin America Biopharmaceuticals Market Size by Application
9.3.1 Latin America Biopharmaceuticals Market Size by Application (2016-2021)
9.3.2 Latin America Biopharmaceuticals Market Size by Application (2022-2027)
9.3.3 Latin America Biopharmaceuticals Market Size by Application (2016-2027)
9.4 Latin America Biopharmaceuticals Market Size by Country
9.4.1 Latin America Biopharmaceuticals Market Size by Country (2016-2021)
9.4.2 Latin America Biopharmaceuticals Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceuticals Market Size (2016-2027)
10.2 Middle East & Africa Biopharmaceuticals Market Size by Type
10.2.1 Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biopharmaceuticals Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2027)
10.3 Middle East & Africa Biopharmaceuticals Market Size by Application
10.3.1 Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biopharmaceuticals Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2027)
10.4 Middle East & Africa Biopharmaceuticals Market Size by Country
10.4.1 Middle East & Africa Biopharmaceuticals Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biopharmaceuticals Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Biopharmaceuticals Introduction
11.1.4 Roche Revenue in Biopharmaceuticals Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Biopharmaceuticals Introduction
11.2.4 Amgen Revenue in Biopharmaceuticals Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Biopharmaceuticals Introduction
11.3.4 AbbVie Revenue in Biopharmaceuticals Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Details
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Biopharmaceuticals Introduction
11.4.4 Sanofi-Aventis Revenue in Biopharmaceuticals Business (2016-2021)
11.4.5 Sanofi-Aventis Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Biopharmaceuticals Introduction
11.5.4 Johnson & Johnson Revenue in Biopharmaceuticals Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Biopharmaceuticals Introduction
11.6.4 Pfizer Revenue in Biopharmaceuticals Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Details
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Biopharmaceuticals Introduction
11.7.4 Novo Nordisk Revenue in Biopharmaceuticals Business (2016-2021)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Biopharmaceuticals Introduction
11.8.4 Eli Lilly Revenue in Biopharmaceuticals Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Biopharmaceuticals Introduction
11.9.4 Novartis Revenue in Biopharmaceuticals Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Biopharmaceuticals Introduction
11.10.4 Merck Revenue in Biopharmaceuticals Business (2016-2021)
11.10.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biopharmaceuticals Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Colony-Stimulating Factor
Table 5. Key Players of Erythropoietin
Table 6. Key Players of Insulin
Table 7. Key Players of Vaccines
Table 8. Key Players of Growth Hormones
Table 9. Key Players of Others
Table 10. Global Biopharmaceuticals Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Biopharmaceuticals Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Biopharmaceuticals Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Biopharmaceuticals Market Share by Regions (2016-2021)
Table 14. Global Biopharmaceuticals Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Biopharmaceuticals Market Share by Regions (2022-2027)
Table 16. Biopharmaceuticals Market Trends
Table 17. Biopharmaceuticals Market Drivers
Table 18. Biopharmaceuticals Market Challenges
Table 19. Biopharmaceuticals Market Restraints
Table 20. Global Biopharmaceuticals Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Biopharmaceuticals Market Share by Players (2016-2021)
Table 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2020)
Table 23. Ranking of Global Top Biopharmaceuticals Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Biopharmaceuticals Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Biopharmaceuticals Product Solution and Service
Table 27. Date of Enter into Biopharmaceuticals Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Biopharmaceuticals Revenue Market Share by Type (2016-2021)
Table 31. Global Biopharmaceuticals Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Biopharmaceuticals Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Biopharmaceuticals Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Biopharmaceuticals Revenue Market Share by Application (2016-2021)
Table 35. Global Biopharmaceuticals Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Biopharmaceuticals Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Biopharmaceuticals Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Biopharmaceuticals Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million)
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Biopharmaceuticals Product
Table 70. Roche Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Amgen Company Details
Table 73. Amgen Business Overview
Table 74. Amgen Biopharmaceuticals Product
Table 75. Amgen Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 76. Amgen Recent Development
Table 77. AbbVie Company Details
Table 78. AbbVie Business Overview
Table 79. AbbVie Biopharmaceuticals Product
Table 80. AbbVie Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 81. AbbVie Recent Development
Table 82. Sanofi-Aventis Company Details
Table 83. Sanofi-Aventis Business Overview
Table 84. Sanofi-Aventis Biopharmaceuticals Product
Table 85. Sanofi-Aventis Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 86. Sanofi-Aventis Recent Development
Table 87. Johnson & Johnson Company Details
Table 88. Johnson & Johnson Business Overview
Table 89. Johnson & Johnson Biopharmaceuticals Product
Table 90. Johnson & Johnson Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 91. Johnson & Johnson Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Biopharmaceuticals Product
Table 95. Pfizer Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. Novo Nordisk Company Details
Table 98. Novo Nordisk Business Overview
Table 99. Novo Nordisk Biopharmaceuticals Product
Table 100. Novo Nordisk Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 101. Novo Nordisk Recent Development
Table 102. Eli Lilly Company Details
Table 103. Eli Lilly Business Overview
Table 104. Eli Lilly Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 105. Eli Lilly Recent Development
Table 106. Novartis Company Details
Table 107. Novartis Business Overview
Table 108. Novartis Biopharmaceuticals Product
Table 109. Novartis Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 110. Novartis Recent Development
Table 111. Merck Company Details
Table 112. Merck Business Overview
Table 113. Merck Biopharmaceuticals Product
Table 114. Merck Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
Table 115. Merck Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceuticals Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Interferon Features
Figure 4. Colony-Stimulating Factor Features
Figure 5. Erythropoietin Features
Figure 6. Insulin Features
Figure 7. Vaccines Features
Figure 8. Growth Hormones Features
Figure 9. Others Features
Figure 10. Global Biopharmaceuticals Market Share by Application: 2020 VS 2027
Figure 11. Tumor Case Studies
Figure 12. Diabetes Case Studies
Figure 13. Cardiovascular Case Studies
Figure 14. Hemophilia Case Studies
Figure 15. Others Case Studies
Figure 16. Biopharmaceuticals Report Years Considered
Figure 17. Global Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Biopharmaceuticals Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Biopharmaceuticals Market Share by Regions: 2020 VS 2027
Figure 20. Global Biopharmaceuticals Market Share by Regions (2022-2027)
Figure 21. Global Biopharmaceuticals Market Share by Players in 2020
Figure 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Biopharmaceuticals Revenue in 2020
Figure 24. Global Biopharmaceuticals Revenue Market Share by Type (2016-2021)
Figure 25. Global Biopharmaceuticals Revenue Market Share by Type (2022-2027)
Figure 26. North America Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Biopharmaceuticals Market Share by Type (2016-2027)
Figure 28. North America Biopharmaceuticals Market Share by Application (2016-2027)
Figure 29. North America Biopharmaceuticals Market Share by Country (2016-2027)
Figure 30. United States Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Biopharmaceuticals Market Share by Type (2016-2027)
Figure 34. Europe Biopharmaceuticals Market Share by Application (2016-2027)
Figure 35. Europe Biopharmaceuticals Market Share by Country (2016-2027)
Figure 36. Germany Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Biopharmaceuticals Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Biopharmaceuticals Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Biopharmaceuticals Market Share by Region (2016-2027)
Figure 46. China Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Biopharmaceuticals Market Share by Type (2016-2027)
Figure 54. Latin America Biopharmaceuticals Market Share by Application (2016-2027)
Figure 55. Latin America Biopharmaceuticals Market Share by Country (2016-2027)
Figure 56. Mexico Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Biopharmaceuticals Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Biopharmaceuticals Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Biopharmaceuticals Market Share by Country (2016-2027)
Figure 62. Turkey Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Roche Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
Figure 66. Amgen Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
Figure 67. AbbVie Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
Figure 68. Sanofi-Aventis Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
Figure 71. Novo Nordisk Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
Figure 72. Eli Lilly Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
Figure 73. Novartis Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
Figure 74. Merck Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
  • Global Biopharmaceuticals Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Biopharmaceuticals market size was valued at US$ 31700 million in 2023. With growing demand in downstream market, the Biopharmaceuticals is forecast to a readjusted size of US$ 55380 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Biopharmaceuticals market. Biopharmaceuticals are expected to show stable growth in the future market. However, product di......
  • Global Bio-Pharma Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Bio-Pharma market: According to our latest research, the global Bio-Pharma market looks promising in the next 5 years. As of 2022, the global Bio-Pharma market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Bio-Pharma market, with a systematical de......
  • Global Bio-pharma Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 91
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Bio-pharma market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Pfizer - F. Hoffmann-La Roche AG - Johnson & Johnson Services - Sanofi, Amgen - AbbVie - Merck & Co., Inc - Biogen Idec - Bayer AG - E......
  • Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), & End User - Global Forecast to 2028
    Published: 24-Nov-2023        Price: US 4950 Onwards        Pages: 273
    “Rising demand for biopharmaceuticals and growing adoption among CDMOs and CMOs are driving the growth of the continuous bioprocessing market.” The global continuous bioprocessing market is projected to reach USD 599 million by 2028 from USD 218 million in 2023, at a CAGR of 22.4% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the increasing adoption of continuous bioprocessing among CDMOs and CMOs. Continuous b......
  • Global Biopharmaceuticals Professional Survey Report 2023, Forecast to 2028
    Published: 20-Nov-2023        Price: US 3280 Onwards        Pages: 139
    A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......
  • Global Biopharmaceuticals Market Research Report 2023, Forecast to 2028
    Published: 20-Nov-2023        Price: US 2680 Onwards        Pages: 160
    A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......
  • 2023-2031 Report on Global Biopharmaceuticals Market by Player, Region, Type, Application and Sales Channel
    Published: 18-Sep-2023        Price: US 2500 Onwards        Pages: 85
    This report studies the Biopharmaceuticals market, covering market size for segment by type (Monoclonal Antibodies, Interferon, etc.), by application (Tumor, Diabetes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, Abbvie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Biopharmaceutic......
  • Global Bio-pharma Market Insights, Forecast to 2029
    Published: 10-Aug-2023        Price: US 4900 Onwards        Pages: 108
    The global Bio-pharma market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of......
  • Biopharmaceuticals Markets in China
    Published: 24-Jul-2023        Price: US 4000 Onwards        Pages: 233
    China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs